Evidence map›Paper›PMID 36411406›Full record

ArticleBMC public health2022

Social capital and willingness to participate in COVID-19 vaccine trials: an Italian case-control study.

Marco Terraneo, Valeria Quaglia, Giampaolo Nuvolati, Marco Bani, Selena Russo, Maria Grazia Strepparava, Serena Capici, Rebecca Cavaliere, Marina Elena Cazzaniga

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Marco TerraneoDepartment of Sociology and Social Research, University of Milano-Bicocca, Milan, Italy.
Valeria QuagliaDepartment of Political Science, Communication and International Relations, University of Macerata, Macerata, Italy.
Giampaolo NuvolatiDepartment of Sociology and Social Research, University of Milano-Bicocca, Milan, Italy.
Marco BaniSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Selena RussoSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Maria Grazia StrepparavaSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Serena CapiciPhase 1 Research Centre, ASST Monza, via Cadore 48, 20900, Monza, Italy.
Rebecca CavaliereRoyal College of Surgeons, University of Medicine and Health Sciences, Dublin, Ireland.
Marina Elena CazzanigaSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. marina.cazzaniga@unimib.it.
University of Milano-Bicocca · ITMylan (Italy) · ITRoyal College of Surgeons in Ireland · IEUniversity of Macerata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhat leads healthy people to enter in a volunteer register for clinical trials? This study aimed to investigate the relationship between the decision to volunteer in clinical trials for a COVID-19 vaccine and social capital, in a sample of healthy volunteers in Italy. Since social capital is characterized by trust, reciprocity, and social and political participation, we claim that it is key in leading individuals to actively take action to protect public health, and to take a risk for the (potential) benefit not only of themselves but for the entire community.

methodsThis study was conducted through the administration of a questionnaire to healthy volunteers registered for a phase 1 clinical trial for a COVID-19 vaccine in the Unit Research Centre of ASST-Monza, in September 2020. The primary purpose of a phase 1 study is to evaluate the safety of a new drug candidate before it proceeds to further clinical studies. To approximate a case-control study, we randomly matched the 318 respondents to healthy volunteers (cases) with 318 people randomly selected by Round 9 of the European Social Survey (controls), using three variables, which we considered to be associated with the decision to volunteer: gender, age, and education level. To execute this matching procedure, we used the "ccmatch" module in STATA.

resultsThe findings highlight the positive impact of social capital in the choice of healthy individuals to volunteer in COVID-19 vaccine clinical trials. Controlling for possible confounding factors, some exemplary results show that people with a high level of general trust have a greater likelihood of volunteering compared to people with low trust (OR = 2.75, CI = 1.58-4.77); we also found that it is more probable that volunteers are people who have actively taken action to improve things compared with people who have not (for individuals who did three or more actions: OR = 7.54, CI = 4.10-13.86). People who reported voting (OR = 3.91, CI = 1.70-8.99) and participating in social activities more than other people of their age (OR = 2.89, CI = 1.82-4.60) showed a higher probability to volunteer.

conclusionsTogether with the adoption of urgent health measures in response to COVID-19, government policymakers should also promote social capital initiatives to encourage individuals to actively engage in actions aimed at protecting collective health. Our findings make an empirical contribution to the research on vaccines and its intersection with social behaviour, and they provide useful insights for policymakers to manage current and future disease outbreaks and to enhance the enrolment in vaccine trials.

Indexed as

COVID-19Social CapitalCase-Control StudiesCOVID-19 VaccinesHumansTrustCOVID-19 VaccinesCOVID-19ItalySocial capitalVaccineVaccine trials willingness

Identifiers

PMID36411406
PMCPMC9677898
OpenAlexW4309669100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.